Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease amyloidosis
Symptom C0018801|heart failure
Sentences 14
PubMedID- 25803181 The clinician must consider a diagnosis of cardiac amyloidosis in patients with heart failure, a restrictive type of cardiomyopathy with ventricular hypertrophy in the absence of valve abnormalities, or uncontrolled arterial hypertension.
PubMedID- 23259134 She had undergone orthotopic heart transplantation 5 weeks earlier for end-stage heart failure due to primary systemic amyloidosis (amyloid light-chain, al) with severe cardiac involvement with restriction diagnosed only few weeks before.
PubMedID- 26493509 A case of primary gastric amyloidosis with fulminant heart failure.
PubMedID- 22949774 We implanted a continuous-flow total heart replacement device in a 55-year-old man who had severe end-stage heart failure due to amyloidosis and no other options for treatment.
PubMedID- 25510353 Cardiac amyloidosis is a cause of diastolic heart failure in which ejection fraction (ef) remains "normal" despite progression of disease.
PubMedID- 23417147 Cardiac involvement is found in approximately 50% of patients with systemic al amyloidosis, leading to congestive heart failure and death2.
PubMedID- 21755769 Many cases of progressive heart failure due to cardiac amyloidosis remain undiagnosed due to the rarity and lack of suspicion on part of physician.
PubMedID- 25374735 The pathogenesis most frequently involves congestive heart failure due to amyloidosis and cardiac disease in the older myeloma population .
PubMedID- 23868674 Systemic light-chain amyloidosis presenting with rapid progressive heart failure.
PubMedID- 21169191 Cardiac involvement occurs frequently in primary amyloidosis and is associated with heart failure hospitalizations and poor survival.
PubMedID- 26224076 Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
PubMedID- 24298723 A 64 year old patient with heart failure due to primary cardiac amyloidosis is described.
PubMedID- 24200511 The purpose of this study was to identify predictors of survival to oht in patients with end-stage heart failure due to al amyloidosis and compare post-oht survival of cardiac amyloid patients with survival of other cardiomyopathy patients undergoing oht.
PubMedID- 23278526 Combined heart-liver transplantation (chltx) is the preferred treatment for patients with heart failure due to familial amyloidosis, but information on outcome of patients with leu111met mutation is limited.

Page: 1